Public filings / RYTM on Yahoo Finance (opens in a new tab)
RYTM: insider buying, 13F holders, analyst moves
Rhythm Pharmaceuticals Inc - US
A summary of public filings about Rhythm Pharmaceuticals Inc - US. For the latest insider history, price chart, analyst changes and activist filings, open the live lookup.
SEC Form 13F · Q2 2026
5 of our 100 managers hold RYTM
Combined reported value $1.67B.
Holders among our 100 managers: 5 in Q3 2023, 5 in Q2 2026.
| Manager | Value | % of portfolio | Change vs Q1 2026 |
|---|---|---|---|
| RA Capital | $740.2M | 6.43% | Unchanged |
| Baker Bros. Advisors | $622.3M | 3.12% | Unchanged |
| Perceptive Advisors | $287.2M | 4.46% | Added |
| Duquesne Family Office | $22.6M | 0.52% | New |
| Tudor Investment | $1.5M | 0.01% | Trimmed |
Important information
Facts from public SEC filings, shown for information only. Not a recommendation. Not individualized investment advice. Gulfstream Capital and its clients may hold positions in securities shown.